Can we estimate the impact of the choices package in pathways to work?

The Pathways to Work programme is an important policy innovation in Britain. It provides greater support, obligations and incentives for claimants of incapacity benefits with the goal of encouraging employment. The programme has various components, including a 'Choices' package. 'Choices' is the collective name for a variety of voluntary schemes intended to improve labour market readiness and opportunities. Previous quantitative research has focused on the overall impact of Pathways to Work while this study was designed to look at the impact of the Choices component

A cost-benefit analysis of pathways to work for new and repeat incapacity benefits claimants

This latest research forms part of a comprehensive independent evaluation of Pathways to Work. The report is based on a cost-benefit analysis conducted by a consortium of researchers from the Institute for Fiscal Studies, the University of Maryland, Baltimore County and the Policy Studies Institute. It examines whether the financial benefits from Pathways are larger or smaller than its costs and the generalisability of some of the quantitative findings. The estimates of costs and benefits relate to new and repeat incapacity benefits claimants in the seven original Jobcentre Plus districts. The overall findings provide a favourable impression of the financial benefits of the Pathways to Work for new and repeat incapacity benefits claimants, for the Exchequer and hence, for society as a whole

Microlasers based on effective index confined slow light modes in photonic crystal waveguides

We present the design, theory and experimental implementation of a low modal volume microlaser based on a line-defect 2D-photonic crystal waveguide. The lateral confinement of low-group velocity modes is controlled by the post-processing of 1 to 3μm wide PMMA strips on top of two dimensional photonic crystal waveguides. Modal volume around 1.3 (λ/n)3can be achieved using this scheme. We use this concept to fabricate microlaser devices from an InP-based heterostructure including InAs0.65P0.35quantum wells emitting around 1550nm and bonded onto a fused silica wafer. We observe stable, room-temperature laser operation with an effective lasing threshold around 0.5mW. © 2008 Optical Society of America

Meningococcal vaccination: Recommendations of the advisory committee on immunization practices, United States, 2020

© 2020. This report compiles and summarizes all recommendations from CDC\u27s Advisory Committee on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States. As a comprehensive summary and update of previously published recommendations, it replaces all previously published reports and policy notes. This report also contains new recommendations for administration of booster doses of serogroup B meningococcal (MenB) vaccine for persons at increased risk for serogroup B meningococcal disease. These guidelines will be updated as needed on the basis of availability of new data or licensure of new meningococcal vaccines. ACIP recommends routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) for adolescents aged 11 or 12 years, with a booster dose at age 16 years. ACIP also recommends routine vaccination with MenACWY for persons aged ≥2 months at increased risk for meningococcal disease caused by serogroups A, C, W, or Y, including persons who have persistent complement component deficiencies; persons receiving a complement inhibitor (e.g., eculizumab [Soliris] or ravulizumab [Ultomiris]); persons who have anatomic or functional asplenia; persons with human immunodeficiency virus infection; microbiologists routinely exposed to isolates of Neisseria meningitidis; persons identified to be at increased risk because of a meningococcal disease outbreak caused by serogroups A, C, W, or Y; persons who travel to or live in areas in which meningococcal disease is hyperendemic or epidemic; unvaccinated or incompletely vaccinated first-year college students living in residence halls; and military recruits. ACIP recommends MenACWY booster doses for previously vaccinated persons who become or remain at increased risk. In addition, ACIP recommends routine use of MenB vaccine series among persons aged ≥10 years who are at increased risk for serogroup B meningococcal disease, including persons who have persistent complement component deficiencies; persons receiving a complement inhibitor persons who have anatomic or functional asplenia; microbiologists who are routinely exposed to isolates of N. meningitidis; and persons identified to be at increased risk because of a meningococcal disease outbreak caused by serogroup B. ACIP recommends MenB booster doses for previously vaccinated persons who become or remain at increased risk. In addition, ACIP recommends a MenB series for adolescents and young adults aged 16-23 years on the basis of shared clinical decision-making to provide short-term protection against disease caused by most strains of serogroup B N. meningitidis

Giant infrared intensity of the Peierls mode at the neutral-ionic phase transition

We present exact diagonalization results on a modified Peierls-Hubbard model for the neutral-ionic phase transition. The ground state potential energy surface and the infrared intensity of the Peierls mode point to a strong, non-linear electron-phonon coupling, with effects that are dominated by the proximity to the electronic instability rather than by electronic correlations. The huge infrared intensity of the Peierls mode at the ferroelectric transition is related to the temperature dependence of the dielectric constant of mixed-stack organic crystals.Comment: 4 pages, 4 figure

Infrared studies of the phase transition in the organic charge transfer salt N-propylquinolinium(TCNQ)2

Polarized infrared and optical reflectance spectroscopies were used to study the structural phase transition in the organic charge-transfer salt N-propylquinolinium ditetracyanoquinodimethane. Above the 220-K phase-transition temperature, the spectra are characteristic of other 1:2 semiconducting charge-transfer salts. Three significant changes occur below T(c). First, the midinfrared charge-transfer band can be resolved into two distinct excitations. Second, there is enhanced oscillator strength, indicative of a larger intratetramer transfer integral in the low-temperature phase. Finally, the vibrational lines split into doublets, providing evidence for an uneven charge distribution within the tetramer. The weakly metallic transport properties above T(c) are attributed to the uniform charge distribution within the tetramer and the high degree of overlap between the intratetramer and intertetramer charge-transfer bands. The transport properties in the low-temperature phase are dominated by charge localization, which may act to reduce the overlap between these low-energy charge-transfer features

One-Dimensional Fermi liquids

I attempt to give a pedagogical overview of the progress which has occurred during the past decade in the description of one-dimensional correlated fermions. Fermi liquid theory based on a quasi-particle picture, breaks down in one dimension because of the Peierls divergence and because of charge-spin separation. It is replaced by a Luttinger liquid whose elementary excitations are collective charge and spin modes, based on the exactly solvable Luttinger model. I review this model and various solutions with emphasis on bosonization (and its equivalence to conformal field theory), and its physical properties. The notion of a Luttinger liquid implies that all gapless 1D systems share these properties at low energies. Chapters 1 and 2 of the article contain an introduction and a discussion of the breakdown of Fermi liquid theory. Chapter 3 describes in detail the solution of the Luttinger model both by bosonization and by Green's functions methods and summarizes the properties of the model, expressed thorugh correlation functions. The relation to conformal field theory is discussed. Chapter 4 of the article introduces the notion of a Luttinger liquid. It describes in much detail the various mappings applied to realistic models of 1D correlated fermions, onto the Luttinger model, as well as important corrections to the Luttinger model properties discussed in Ch.3. Chapter 5 describes situations where the Luttinger liquid is not a stable fixed point, and where spin or charge gaps open in at least one channel. Chapter 6 discusses multi-band and multichain problems, in particular the stability of a Luttinger liquid with respect to interchain hopping. Ch. 7 gives a brief summary of experimental efforts to uncover Luttinger liquid correlations in quasi-1D materials.Comment: uuencoded Latex files and postscript figures, one Readme-file approx 160 pages + 13 figures; to be published by Reports on Progress in Physic

The global meningitis genome partnership.

Genomic surveillance of bacterial meningitis pathogens is essential for effective disease control globally, enabling identification of emerging and expanding strains and consequent public health interventions. While there has been a rise in the use of whole genome sequencing, this has been driven predominately by a subset of countries with adequate capacity and resources. Global capacity to participate in surveillance needs to be expanded, particularly in low and middle-income countries with high disease burdens. In light of this, the WHO-led collaboration, Defeating Meningitis by 2030 Global Roadmap, has called for the establishment of a Global Meningitis Genome Partnership that links resources for: N. meningitidis (Nm), S. pneumoniae (Sp), H. influenzae (Hi) and S. agalactiae (Sa) to improve worldwide co-ordination of strain identification and tracking. Existing platforms containing relevant genomes include: PubMLST: Nm (31,622), Sp (15,132), Hi (1935), Sa (9026); The Wellcome Sanger Institute: Nm (13,711), Sp (> 24,000), Sa (6200), Hi (1738); and BMGAP: Nm (8785), Hi (2030). A steering group is being established to coordinate the initiative and encourage high-quality data curation. Next steps include: developing guidelines on open-access sharing of genomic data; defining a core set of metadata; and facilitating development of user-friendly interfaces that represent publicly available data

The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.

Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide and is associated with high case fatality rates and serious life-long complications among survivors. Twelve serogroups are recognised, of which six (A, B, C, W, X and Y) are responsible for nearly all cases of invasive meningococcal disease (IMD). The incidence of IMD and responsible serogroups vary widely both geographically and over time. For the first time, effective vaccines against all these serogroups are available or nearing licensure. Over the past two decades, IMD incidence has been declining across most parts of the world through a combination of successful meningococcal immunisation programmes and secular trends. The introduction of meningococcal C conjugate vaccines in the early 2000s was associated with rapid declines in meningococcal C disease, whilst implementation of a meningococcal A conjugate vaccine across the African meningitis belt led to near-elimination of meningococcal A disease. Consequently, other serogroups have become more important causes of IMD. In particular, the emergence of a hypervirulent meningococcal group W clone has led many countries to shift from monovalent meningococcal C to quadrivalent ACWY conjugate vaccines in their national immunisation programmes. Additionally, the recent licensure of two protein-based, broad-spectrum meningococcal B vaccines finally provides protection against the most common group responsible for childhood IMD across Europe and Australia. This review describes global IMD epidemiology across each continent and trends over time, the serogroups responsible for IMD, the impact of meningococcal immunisation programmes and future needs to eliminate this devastating disease